axial3D, a top medical 3D printing firm, has announced the closing of a USD million funding round. The pioneering company is building an robotic 3D printing solution for the healthcare sector that is dramatically advancing the standards and efficiency of surgery worldwide.
 
The funding round was led by London-based Imprimatur Capital Fund Management, an international science and technology investor. The round was also supported by a U.S. investment consortium containing of a number of surgical angel investors. axial3D's previous institutional investors, Techstart Ventures, Clarendon Fund Managers and Innovation Ulster Ltd, also participated in the round. The investment will support axial3D's fast development plans for the USA. The company plans to open an office in the region, following previous customer wins and as other healthcare institutions sign up to the service. The firm is making roles within the increasing U.S. market and at its base in Belfast to help the large growth and ensure continuous innovation.
 
There's a big concentration on expanding its machine learning team, which builds groundbreaking automated algorithms that make access to medical 3D printing better than ever for hospitals. Daniel Crawford, CEO at axial3D, said, 'The closure of this investment round marks an important milestone for our company. It will accelerate our growth within our expanding markets and enable us to bring our 3D printing solution to more healthcare organizations, helping them to drive down costs, improve compliance and, ultimately, enhance patient care.' He continued, 'Continuous innovation is crucial to bring the best solutions to market and keep up with customer demand. Following our recent collaborations with Tallahassee Memorial Healthcare and University Hospital Basel, we will focus further on the North American and European markets. This includes opening an office in the USA and recruiting more talent into our team, particularly to grow our machine learning capability. This will enable us to maintain to innovate and find new ways to bring 3D printing on-demand to the entire healthcare sector.' Dr. Christopher Rumana, Neurosurgeon & Charmain of the Board at Tallahassee Memorial Healthcare (TMH), has been a user of axial3D's medical 3D printing service since 2018 and is part of the cohort who are now investing in the company. 'axial3D has built a scalable, accessible platform for clinicians to access 3D printing without the capital expenditure or manpower typically required. Having been in the medical field for over two decades, I have seen how technology boosts patient care. With TMH being a user of axial3D's service, our own patients have been absolutely affected by the use of 3D printing. I want to see this service adopted in more healthcare institutions across the USA so that everyone who needs it can gain from the technology.'
 
Since 2011, Dr. Rumana has been a user of the Board of Directors at Tallahassee Memorial Hospital, where he currently serves as the Chairman of the Board. The global 3D printing medical devices market is estimated to see a compounding annual growth rate of 23%, largely due to the increasing adoption of 3D printing technology within the medical sector. axial3D has a range of solutions for healthcare institutions at every stage of their 3D printing journey, from those seeking a one-off custom print, to those with an established 3D print lab hoping to increase compliance and productivity, while reducing operating costs.



This article is originally posted on Tronserve.com